Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Merit Medical Systems (MMSI) stocks in Canada
Learn how to easily invest in Merit Medical Systems stocks.
Merit Medical Systems is a medical instruments & supplies business based in the US. Merit Medical Systems stocks (MMSI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $63.68 – a decrease of 0.95% over the previous week. Merit Medical Systems employs 6,700 staff and has a trailing 12-month revenue of around $1.1 billion.
How to buy shares in Merit Medical Systems
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MMSI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Merit Medical Systems?
- Has coronavirus impacted Merit Medical Systems shares?
- Merit Medical Systems shares summary
- Compare share dealing platforms
- Is Merit Medical Systems stock a buy or sell?
- Merit Medical Systems performance over time
- Are Merit Medical Systems shares over-valued?
- Merit Medical Systems's financials
- How volatile are Merit Medical Systems shares?
- Does Merit Medical Systems pay a dividend?
- Have Merit Medical Systems shares ever split?
- Other common questions
Merit Medical Systems stock price (NASDAQ:MMSI)Use our graph to track the performance of MMSI stocks over time.
Merit Medical Systems shares at a glance
|Latest market close||$55.19|
|52-week range||$52.43 - $73.85|
|50-day moving average||$63.15|
|200-day moving average||$65.25|
|Wall St. target price||$78.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.77|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Merit Medical Systems stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Merit Medical Systems price performance over time
|1 week (2022-01-20)||0.04%|
|1 month (2021-12-23)||-13.40%|
|3 months (2021-10-27)||-19.41%|
|6 months (2021-07-27)||-14.47%|
|1 year (2021-01-27)||-5.55%|
|2 years (2020-01-24)||50.87%|
|3 years (2019-01-25)||1.12%|
|5 years (2017-01-26)||118.57%|
Is Merit Medical Systems under- or over-valued?
Valuing Merit Medical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merit Medical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Merit Medical Systems's P/E ratio
Merit Medical Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, Merit Medical Systems shares trade at around 73x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Merit Medical Systems's PEG ratio
Merit Medical Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merit Medical Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Merit Medical Systems's EBITDA
Merit Medical Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $167.5 million.
The EBITDA is a measure of a Merit Medical Systems's overall financial performance and is widely used to measure a its profitability.
Merit Medical Systems financials
|Revenue TTM||$1.1 billion|
|Operating margin TTM||7.66%|
|Gross profit TTM||$401.2 million|
|Return on assets TTM||3.05%|
|Return on equity TTM||4.44%|
|Market capitalisation||$3.1 billion|
TTM: trailing 12 months
Merit Medical Systems share dividends
We're not expecting Merit Medical Systems to pay a dividend over the next 12 months.
Have Merit Medical Systems's shares ever split?
Merit Medical Systems's shares were split on a 5:4 basis on 5 May 2011. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Merit Medical Systems shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Merit Medical Systems shares which in turn could have impacted Merit Medical Systems's share price.
Merit Medical Systems share price volatility
Over the last 12 months, Merit Medical Systems's shares have ranged in value from as little as $52.43 up to $73.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Merit Medical Systems's is 1.1095. This would suggest that Merit Medical Systems's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Merit Medical Systems overview
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally.
Stocks similar to Merit Medical Systems
Merit Medical Systems in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.